Evidence map›Paper›PMID 25368159›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.

Tohru Tezuka, Akane Inoue, Taisuke Hoshi, Scott D Weatherbee, Robert W Burgess, Ryo Ueta, Yuji Yamanashi

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Curing SMA: Are we there yet?Gene therapy · 2023
    Review
  6. Article
  7. A link between agrin signalling and CaScientific reports · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Tohru TezukaDivision of Genetics, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan;
Akane InoueDivision of Genetics, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan;
Taisuke HoshiDivision of Genetics, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan;
Scott D WeatherbeeDepartment of Genetics, Yale University, New Haven, CT 06520; and.
Robert W BurgessThe Jackson Laboratory, Bar Harbor, ME 04609.
Ryo UetaDivision of Genetics, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan;
Yuji YamanashiDivision of Genetics, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan; yyamanas@ims.u-tokyo.ac.jp.
Tokyo University of Science · JPJackson Laboratory · USThe University of Tokyo · JPYale University · US

Funding

Genetics of the Neuromuscular Junction: Mechanisms and Disease ModelsR01NS054154 · NINDS · JACKSON LABORATORY · PI BURGESS, ROBERT W. · 2006 to 2019
$6.0M
Skin Development Analysis in Mutant Mouse LinesR01AR059687 · NIAMS · YALE UNIVERSITY · PI WEATHERBEE, SCOTT DONALD · 2011 to 2015
$1.8M
Genetics of the Neuromuscular Junction: Mechanisms and Disease ModelsR56NS054154 · NINDS · JACKSON LABORATORY · PI BURGESS, ROBERT W. · 2015 to 2015
$613k
NIAMS NIH HHS R01 AR059687NINDS NIH HHS NS054154NINDS NIH HHS R01 NS054154NINDS NIH HHS R56 NS054154
6 · The paper itself

Abstract

The motoneural control of skeletal muscle contraction requires the neuromuscular junction (NMJ), a midmuscle synapse between the motor nerve and myotube. The formation and maintenance of NMJs are orchestrated by the muscle-specific receptor tyrosine kinase (MuSK). Motor neuron-derived agrin activates MuSK via binding to MuSK's coreceptor Lrp4, and genetic defects in agrin underlie a congenital myasthenic syndrome (an NMJ disorder). However, MuSK-dependent postsynaptic differentiation of NMJs occurs in the absence of a motor neuron, indicating a need for nerve/agrin-independent MuSK activation. We previously identified the muscle protein Dok-7 as an essential activator of MuSK. Although NMJ formation requires agrin under physiological conditions, it is dispensable for NMJ formation experimentally in the absence of the neurotransmitter acetylcholine, which inhibits postsynaptic specialization. Thus, it was hypothesized that MuSK needs agrin together with Lrp4 and Dok-7 to achieve sufficient activation to surmount inhibition by acetylcholine. Here, we show that forced expression of Dok-7 in muscle enhanced MuSK activation in mice lacking agrin or Lrp4 and restored midmuscle NMJ formation in agrin-deficient mice, but not in Lrp4-deficient mice, probably due to the loss of Lrp4-dependent presynaptic differentiation. However, these NMJs in agrin-deficient mice rapidly disappeared after birth, and postsynaptic specializations emerged ectopically throughout myotubes whereas exogenous Dok-7-mediated MuSK activation was maintained. These findings demonstrate that the MuSK activator agrin plays another role essential for the postnatal maintenance, but not for embryonic formation, of NMJs and also for the postnatal, but not prenatal, midmuscle localization of postsynaptic specializations, providing physiological and pathophysiological insight into NMJ homeostasis.

Indexed as

AgrinAlternative SplicingAnimalsDiaphragmEnzyme ActivationFemaleLDL-Receptor Related ProteinsLongevityMaleMiceMice, TransgenicMuscle Fibers, SkeletalMuscle ProteinsNeuromuscular JunctionNeuromuscular Junction DiseasesPhosphorylationAgrinDok-7 protein, mouseLDL-Receptor Related ProteinsLrp4 protein, mouseMuscle ProteinsMuSK protein, mouseReceptor Protein-Tyrosine KinasesReceptors, CholinergicReceptors, LDLRecombinant Fusion ProteinsDok-7Lrp4neuromuscular junctionpostsynaptic specialization

Identifiers

PMID25368159
PMCPMC4246289
OpenAlexW2101557097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.